Clinical Trial Update: Phenotypic and Molecular Characterisation of Cerebral Amyloid Angiopathy

View source ↗

Summary

This clinical trial aims to characterize the phenotypic and molecular features of cerebral amyloid angiopathy and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Amyloid Angiopathy

Snippet

Sponsor: University Hospital, Rouen | Conditions: Cerebral Amyloid Aβ Angiopathy | Status: RECRUITING